Metraipolis › archive › dc_165aa39241bc

Enhancing Optogenetics-Based Cancer Therapy Via Nanotechnology — Europe PMC PMID:42494572

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42494572
DOI
10.1002/exp.20250399
License (as archived)
solo-consultazione
Archived
2026-10-19T07:47:25.689Z
SHA-256 of the archived text
08fc5b48fb9a701254427be5df711a8251b5f7048e97b0dd9dc4474041ec5574
Stable URL of this page
https://metraipolis.com/documento/dc_165aa39241bc

How to cite

Enhancing Optogenetics-Based Cancer Therapy Via Nanotechnology — Europe PMC PMID:42494572 — Europe PMC (en), https://europepmc.org/article/MED/42494572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_165aa39241bc (Metraipolis archive dc_165aa39241bc, sha256 08fc5b48fb9a701254427be5df711a8251b5f7048e97b0dd9dc4474041ec5574)
BibTeX
@misc{dc165aa39241bc,
  title = {Enhancing Optogenetics-Based Cancer Therapy Via Nanotechnology — Europe PMC PMID:42494572},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42494572},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_165aa39241bc; sha256 08fc5b48fb9a701254427be5df711a8251b5f7048e97b0dd9dc4474041ec5574},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42494572. Agents can read the archived copy with the MCP tool read_document.